Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 191
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Rodotium 162 mg/ml V/MRP/24/0022 Huvepharma EOOD, Bulgārija QJ01XQ01 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tiamulin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet AD, Bulgārija
Date of authorisation/renewal: 07-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Mar-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (07-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0022-01 1 Stikla pudele, 100 ml -
Equisedan 10 mg/ml V/MRP/13/0033 Vetcare Oy, Somija QN05CM90 horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Laboratorios SYVA S.A.U, Spānija;Tairgi Tread-Lia Baile na Sceilge Teo (Trading as Ballinskelligs Veterinary Products), Īrija
Date of authorisation/renewal: 30-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0033-01 10 mg/ml 1 Stikla flakons, 10 ml -
V/MRP/13/0033-02 10 mg/ml 1 Stikla flakons, 15 ml -
Equibactin vet. - V/DCP/19/0040 Dechra Regulatory B.V., Nīderlande QJ01EW10 horses Vairāk

Medicinal product information

Pharmaceutical form: oral powder
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 02082019LI (02-Aug-2019)
Labelling text: [PDF] 02082019M (02-Aug-2019)
Summary of product characteristics: [PDF] 02082019ZA (02-Aug-2019)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0040-01 250/50 mg 1 ABPE trauciņš, 105 g -
V/DCP/19/0040-02 250/50 mg 1 ABPE trauciņš, 210 g -
V/DCP/19/0040-03 250/50 mg 1 ABPE trauciņš, 420 g -
V/DCP/19/0040-04 250/50 mg 1 Polipropilēna trauciņš, 840 g -
V/DCP/19/0040-05 250/50 mg 10 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-06 250/50 mg 20 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-07 250/50 mg 28 PET/AL/PE maisiņš, 5 g -
V/DCP/19/0040-08 250/50 mg 10 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-09 250/50 mg 20 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-10 250/50 mg 28 PET/AL/PE maisiņš, 15 g -
V/DCP/19/0040-12 250/50 mg 10 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-13 250/50 mg 20 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-14 250/50 mg 28 PET/AL/PE maisiņš, 30 g -
V/DCP/19/0040-16 250/50 mg 10 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-17 250/50 mg 20 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-18 250/50 mg 28 PET/AL/PE maisiņš, 60 g -
V/DCP/19/0040-20 250/50 mg 10 PET/AL/PE maisiņš, 100 g -
Versiguard Rabies - V/MRP/06/1668 Zoetis Belgium S.A., Beļģija QI07AA02 ferrets; cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Rabies virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/06/1668-01 10 Flakons, 1 deva -
V/MRP/06/1668-12 10 Flakons, 10 deva -
V/MRP/06/1668-16 1 Flakons, 1 deva -
Lineomam LC - V/MRP/17/0024 Bioveta, a.s., Čehija QJ51RF03 cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary solution
International name (active substance): Lincomycin hydrohloride, Neomycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 230221LI (24-Feb-2021)
Labelling text: [DOCX] 230221M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300523ZA (31-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/17/0024-01 24 Injektors, 10 ml -
Profexx 50 mg/ml V/DCP/24/0025 Alfasan Nederland BV, Nīderlande QM01AE91 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 26-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0025-01 1 Stikla flakons, 50 ml -
V/DCP/24/0025-02 1 Stikla flakons, 100 ml -
V/DCP/24/0025-03 1 Stikla flakons, 250 ml -
Cartaxx 50 mg/ml V/DCP/24/0026 Alfasan Nederland BV, Nīderlande QM01AE91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 26-Mar-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0026-01 1 Stikla flakons, 10 ml -
V/DCP/24/0026-02 1 Stikla flakons, 20 ml -
V/DCP/24/0026-03 1 Stikla flakons, 50 ml -
Nobivac Tricat Trio - V/MRP/07/1709 Intervet International B.V., Nīderlande QI06AD04 cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live attenuated feline rhinotracheitis virus, strain G2620A,Live, attenuated feline calici virus,Live attenuated feline panleucopenia virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Jan-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1709-01 5 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-02 10 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-03 25 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-04 50 Stikla flakons (kartona kastē), 1 deva -
V/MRP/07/1709-05 5 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-06 10 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-07 25 Stikla flakons (plastikāta kastē), 1 deva -
V/MRP/07/1709-08 50 Stikla flakons (plastikāta kastē), 1 deva -
Nobivac Pi - V/MRP/22/0003 Intervet International B.V., Nīderlande QI07AD08 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine parainfluenza virus, strain Cornell, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/22/0003-01 5 Stikla flakons, 1 deva -
V/MRP/22/0003-02 10 Stikla flakons, 1 deva -
V/MRP/22/0003-03 25 Stikla flakons, 1 deva -
V/MRP/22/0003-04 50 Stikla flakons, 1 deva -
Oxytocin 10 IU/ml 10 IU/ml V/NRP/96/0314 Bela-pharm GmbH&Co.KG, Vācija QH01BB02 cattle; pigs; sheep; goats; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Oxytocin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0314-01 16,6 µg/ml 1 Stikla flakons, 10 ml -
V/NRP/96/0314-02 16,6 µg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0314-03 16,6 µg/ml 1 Stikla flakons, 100 ml -
V/NRP/96/0314-04 16,6 µg/ml 5 Stikla flakons, 10 ml -
V/NRP/96/0314-05 16,6 µg/ml 6 Stikla flakons, 10 ml -
V/NRP/96/0314-06 16,6 µg/ml 10 Stikla flakons, 10 ml -
V/NRP/96/0314-07 16,6 µg/ml 12 Stikla flakons, 10 ml -
V/NRP/96/0314-08 16,6 µg/ml 6 Stikla flakons, 50 ml -
V/NRP/96/0314-09 16,6 µg/ml 12 Stikla flakons, 50 ml -
V/NRP/96/0314-10 16,6 µg/ml 6 Stikla flakons, 100 ml -
V/NRP/96/0314-11 16,6 µg/ml 12 Stikla flakons, 100 ml -
Alpramil mg V/DCP/22/0018 Alfasan Nederland BV, Nīderlande QP54AB51 dogs

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0018-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0018-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0018-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0018-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0018-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0019 Alfasan Nederland BV, Nīderlande QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0019-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0019-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0019-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0019-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0019-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0020 Alfasan Nederland BV, Nīderlande QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0020-01 1 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-02 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-03 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0020-04 10 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-05 10 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-06 10 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/22/0020-07 25 Al/OPA/Al/PVH blisteris, 1 tablete -
V/DCP/22/0020-08 25 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/22/0020-09 25 Al/OPA/Al/PVH blisteris, 4 tablete -
Alpramil mg V/DCP/22/0021 Alfasan Nederland BV, Nīderlande QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): MILBEMYCINE OXIME, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-May-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0021-01 1 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-02 1 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-03 1 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0021-04 10 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-05 10 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-06 10 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
V/DCP/22/0021-07 25 alumīnija/PVC/PE/PVDC blisteris, 1 tablete -
V/DCP/22/0021-08 25 alumīnija/PVC/PE/PVDC blisteris, 2 tablete -
V/DCP/22/0021-09 25 alumīnija/PVC/PE/PVDC blisteris, 4 tablete -
Tulaject 100 mg/ml V/DCP/20/0059 Alivira Animal Health Limited;, Īrija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS KARIZOO, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Jan-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0059-01 100 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/20/0059-02 100 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/20/0059-03 100 mg/ml 1 Stikla flakons, 250 ml -
ReproCyc PRRS EU - V/DCP/15/0007 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AD03 pigs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live attenuated porcine reproductive and respiratory syndrome virus, strain 94881
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0007-01 1 Stikla flakons, 10 deva -
V/DCP/15/0007-02 1 Stikla flakons, 50 deva [PDF] [PDF] [DOCX]
V/DCP/15/0007-03 1 Stikla flakons, 100 deva -
V/DCP/15/0007-04 12 Stikla flakons, 10 deva -
V/DCP/15/0007-05 25 Stikla flakons, 10 deva -
V/DCP/15/0007-06 12 Stikla flakons, 50 deva -
V/DCP/15/0007-07 25 Stikla flakons, 50 deva -
V/DCP/15/0007-08 12 Stikla flakons, 100 deva -
V/DCP/15/0007-09 25 Stikla flakons, 100 deva -
Caremast vet 600 mg V/DCP/16/0004 Vetcare Oy, Somija QJ51CE09 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Benzylpenicillin procaine monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KELA N.V., Beļģija
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0004-01 600 mg 3 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-02 600 mg 5 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-03 600 mg 20 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-04 600 mg 40 Polipropilēna pilnšļirce, 1 deva -
V/DCP/16/0004-05 600 mg 100 Polipropilēna pilnšļirce, 1 deva -
Cevac Salmovac - V/MRP/21/0074 Ceva Sante Animale', Francija QI01AE01 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija;IDT Biologika GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0074-01 1 Stikla flakons, 1000 deva -
V/MRP/21/0074-02 10 Stikla flakons, 1000 deva -
V/MRP/21/0074-03 1 Stikla flakons, 5000 deva [PDF] [PDF] [DOCX]
V/MRP/21/0074-04 12 Stikla flakons, 5000 deva -
V/MRP/21/0074-05 1 Stikla flakons, 2500 deva -
V/MRP/21/0074-06 10 Stikla flakons, 2500 deva -
Biocan M - V/NRP/97/0594 Bioveta, a.s., Čehija QI06AQ02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Microsporum canis, strain CCM 8211, inactivated
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/97/0594-01 10 Flakons, 1 ml -
V/NRP/97/0594-03 2 Flakons, 1 ml -
V/NRP/97/0594-05 20 Flakons, 1 ml -
V/NRP/97/0594-06 50 Flakons, 1 ml -
V/NRP/97/0594-07 100 Flakons, 1 ml -
Biocan DHPPi - V/NRP/01/1332 Bioveta, a.s., Čehija QI07AD04 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Attenuated canine distemper virus,Attenuated canine parainfluenza virus,Attenuated canine contagious laryngotracheitis virus,Live attenuated Canine Parvovirus (CPV)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-May-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1332-01 5 Flakons, 1 ml -
V/NRP/01/1332-02 10 Flakons, 1 ml -
V/NRP/01/1332-03 50 Flakons, 1 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy